Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | RANTES | 10454.0 | 65 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | RANTES | 9138.0 | 63 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | RANTES | 1165.0 | 69 | |
N2586 | Poly(I:C) | 2 | ug/mL | 3 | RANTES | 12531.0 | 63 | ||||
N2586 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | RANTES | 14007.0 | 59 | |
N2586 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | RANTES | 13851.5 | 64 | |
N2586 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | RANTES | 15680.0 | 55 | |
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | RANTES | 297.5 | 50 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | RANTES | 10412.0 | 63 | |
RA2159 | 3 | RANTES | 96.0 | 73 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | RANTES | 69.5 | 38 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | RANTES | 69.0 | 53 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | RANTES | 68.0 | 53 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | RANTES | 82.5 | 58 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | RANTES | 49.5 | 62 | ||||
RA2159 | 3 | RANTES | 71.0 | 79 | |||||||
N2586 | 3 | RANTES | 143.0 | 50 | |||||||
N2586 | PD184352 | 0.1 | uM | 3 | RANTES | 75.5 | 56 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 3 | RANTES | 55.5 | 58 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 3 | RANTES | 63.0 | 62 | ||||
N2586 | Tofacitinib | 0.3 | uM | 3 | RANTES | 55.0 | 67 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | RANTES | 100.0 | 55 | ||||
N2586 | 3 | RANTES | 112.0 | 43 | |||||||
RA2159 | Visfatin | 1 | ng/mL | 3 | RANTES | 127.0 | 55 | ||||
RA2159 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 3 | RANTES | 76.0 | 56 |